FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation, updating the labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy
• Neuropathic Pain
• Trigeminal Neuralgia

Drugs mentioned

• TEGRETOL (CARBAMAZEPINE)

Snippet

SUPPL AP for TEGRETOL (CARBAMAZEPINE)